Can We Afford Curative Therapies Without Sharing Risks? Perspectives on HTA and Affordability in This New Innovation Era

By Xcenda |

Xcenda joined more than 5,000 attendees from around the world at ISPOR Europe 2019 in Copenhagen, Denmark and presented an educational symposium on Tuesday, November 5, 2019. Jay Jackson, Sr. Vice President of Consulting Services, and Dr. Thomas Mittendorf, Managing Director of Xcenda GmbH, along with industry leaders in France, Italy, and UK discussed and presented insights around value assessment and risk-sharing for new and innovative curative therapies.